Comparing guidelines for the treatment of inflammatory bowel disease

Stephen B. Hanauer, Joseph B. Kirsner

Research output: Contribution to journalArticlepeer-review


As we enter into the era of 'personalized medicine', many of the recommendations of 'evidence-based medicine' require scrutiny and adaptation to optimize individual outcomes. Several examples of these discrepancies are exemplified by the topics of aminosalicylate use in Crohn's disease, early use of biologic agents that target TNF and the role of calcineurin inhibitors versus anti-TNF agents in steroid-refractory ulcerative colitis.

Original languageEnglish (US)
Pages (from-to)360-362
Number of pages3
JournalDigestive Diseases
Issue number3-4
StatePublished - Nov 2013

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Comparing guidelines for the treatment of inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this